Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
Cosentyx (Secukinumab)is a recombinant human monoclonal IgG1/κ antibody that binds specifically to IL-17A. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line. Secukinumab has a molecular mass of approximately 151 kDa; both heavy chains of secukinumab contain oligosaccharide chains.
Secukinumab is supplied at a concentration of 150 mg/mL as a sterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution of pH 5.8, which contains 4.656 mg/mL L-histidine/histidine hydrochloride monohydrate, 0.6 mg/mL polysorbate 80, and 92.43 mg/mL sucrose.
Properties
Name | Secukinumab |
CAS NO. | 875356-43-7 |
Type | Whole antibody |
Source | Human |
Target | IL17A |
Clone | Monoclone |
Molecular Weight | 151 kDa |
Formula | C6584H10134N1754O2042S44 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China (Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Secukinumab
